BRPI0507664A - compostos com atividade antitumor - Google Patents

compostos com atividade antitumor

Info

Publication number
BRPI0507664A
BRPI0507664A BRPI0507664-1A BRPI0507664A BRPI0507664A BR PI0507664 A BRPI0507664 A BR PI0507664A BR PI0507664 A BRPI0507664 A BR PI0507664A BR PI0507664 A BRPI0507664 A BR PI0507664A
Authority
BR
Brazil
Prior art keywords
compounds
antitumor activity
antitumor
optionally
formula
Prior art date
Application number
BRPI0507664-1A
Other languages
English (en)
Inventor
Gianfranco Peluso
Menotti Calvani
Original Assignee
Defiante Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Defiante Farmaceutica Lda filed Critical Defiante Farmaceutica Lda
Publication of BRPI0507664A publication Critical patent/BRPI0507664A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

COMPOSTOS COM ATIVIDADE ANTITUMOR. A presente invenção refere-se ao uso de compostos de fórmula (I), onde X, Y e Z são definidos como na descrição da invenção, para a preparação de um medicamento antitumor, opcionalmente em combinação com diferentes substâncias biologicamente ativas.
BRPI0507664-1A 2004-02-12 2005-02-08 compostos com atividade antitumor BRPI0507664A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000230A ITMI20040230A1 (it) 2004-02-12 2004-02-12 Composti ad attivita' antitumorale
PCT/EP2005/001257 WO2005077354A1 (en) 2004-02-12 2005-02-08 Compounds having antitumor activity

Publications (1)

Publication Number Publication Date
BRPI0507664A true BRPI0507664A (pt) 2007-07-17

Family

ID=34856910

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507664-1A BRPI0507664A (pt) 2004-02-12 2005-02-08 compostos com atividade antitumor

Country Status (20)

Country Link
US (1) US7652066B2 (pt)
EP (1) EP1713461B1 (pt)
JP (1) JP2007522165A (pt)
KR (1) KR101220331B1 (pt)
CN (1) CN1917867B (pt)
AR (1) AR047742A1 (pt)
AT (1) ATE476973T1 (pt)
AU (1) AU2005211906B2 (pt)
BR (1) BRPI0507664A (pt)
CA (1) CA2556069C (pt)
CY (1) CY1111048T1 (pt)
DE (1) DE602005022828D1 (pt)
DK (1) DK1713461T3 (pt)
ES (1) ES2350695T3 (pt)
HK (1) HK1099687A1 (pt)
IT (1) ITMI20040230A1 (pt)
PL (1) PL1713461T3 (pt)
SI (1) SI1713461T1 (pt)
TW (1) TWI361802B (pt)
WO (1) WO2005077354A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314144B2 (en) * 2004-02-12 2012-11-20 Defiante Farmaceutica, S.A. Compounds having antitumor activity
WO2008109991A1 (en) 2007-03-09 2008-09-18 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer
US8680282B2 (en) 2007-08-01 2014-03-25 University Health Network Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
JP5474047B2 (ja) * 2008-04-29 2014-04-16 エフ．ホフマン−ラ ロシュ アーゲー ４−ジメチルアミノ酪酸誘導体
JP2011525530A (ja) * 2008-06-24 2011-09-22 ダラ・バイオサイエンシズ，インコーポレイテッド 酵素阻害剤およびその使用
JP5746988B2 (ja) * 2012-02-15 2015-07-08 ライオン株式会社 カプセル皮膜及びカプセル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
CA2391277A1 (en) * 1999-11-12 2001-05-17 The Johns Hopkins University School Of Medicine Treating cancer by increasing intracellular malonyl coa levels

Also Published As

Publication number Publication date
WO2005077354A1 (en) 2005-08-25
CN1917867B (zh) 2011-03-16
CA2556069C (en) 2013-04-23
ITMI20040230A1 (it) 2004-05-12
CA2556069A1 (en) 2005-08-25
CY1111048T1 (el) 2015-06-11
DK1713461T3 (da) 2010-11-22
EP1713461A1 (en) 2006-10-25
TWI361802B (en) 2012-04-11
DE602005022828D1 (de) 2010-09-23
KR20060134059A (ko) 2006-12-27
KR101220331B1 (ko) 2013-01-09
US20080227683A1 (en) 2008-09-18
US7652066B2 (en) 2010-01-26
AR047742A1 (es) 2006-02-15
TW200530154A (en) 2005-09-16
HK1099687A1 (en) 2007-08-24
ATE476973T1 (de) 2010-08-15
AU2005211906B2 (en) 2009-07-30
PL1713461T3 (pl) 2011-01-31
AU2005211906A1 (en) 2005-08-25
EP1713461B1 (en) 2010-08-11
CN1917867A (zh) 2007-02-21
ES2350695T3 (es) 2011-01-26
JP2007522165A (ja) 2007-08-09
SI1713461T1 (sl) 2010-12-31

Similar Documents

Publication Publication Date Title
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0514665A2 (pt) compostos com atividade antibacteriana, composições farmacêuticas e uso dos mesmos
UY30759A1 (es) Compuestos quimicos
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
MX2009004766A (es) Derivados de espiroindolinona.
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
UY28662A1 (es) Agente endoparasiticida para administracion topica
UY29732A1 (es) Derivados de benzotiazolonas, procesos de preparación, composiciones y combinaciones que los contienen y aplicaciones
BRPI0516488A (pt) azolidinonas de 1,5-naftiridina tendo atividade antiproliferativa de cdk1
BRPI0620436A8 (pt) compostos miméticos de lisina modificados, composição farmacêutica e uso
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
UY30195A1 (es) Derivados de fenetanolamina, procedimiento de preparacion, composiciones que los contienen y aplicaciones
CL2009000035A1 (es) Compuestos derivados 3-espiro-heterociclo-1il-5h-ciclopentan[d]pirimidin-indol, util para inhibir la actividad de akt quinasa; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades tal como cancer, fibrosis quistica, diabetes, enfermedad de alzheimer, entre otras.
AR051765A1 (es) Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
UY31079A1 (es) Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos
UY30808A1 (es) Derivados de benzotiazolonas, composiciones conteniéndolos y aplicaciones
BRPI0507664A (pt) compostos com atividade antitumor
BRPI0506888A (pt) composições de suplemento lìquido compreendendo um ou mais medicamentos
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
UY29768A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: DEFIANTE FARMACEUTICA, S.A. (PT)

Free format text: ALTERADO DE: DEFIANTE FARMACEUTICA LDA

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.